Intalere Releases Inflationary Update for Healthcare Supplies

Share Article

Intalere, the healthcare industry leader in delivering optimal cost, quality and clinical outcomes, recently released its updated Inflationary Indices to members for the first half of 2017, featuring company and industry projections for inflation rates across contract portfolio categories.

Intalere, the healthcare industry leader in delivering optimal cost, quality and clinical outcomes, recently released its updated Inflationary Indices to members for the first half of 2017, featuring company and industry projections for inflation rates across contract portfolio categories.

“Market dynamics regarding pricing issues play a major role in planning cost reduction initiatives for our members,” said Tom Wessling, Intalere’s vice president of contracting operations. “These projections offer decision support and assist in the planning process.”

The Intalere Inflationary Indices is published biannually with updates to reflect any market trends or changes. The projections represent industry inflationary performance, actual pricing through Intalere contracts and programs, and the expected impact of upcoming contract bids.

The report covers categories including diagnostic imaging, environmental services, executive resources, foodservice, laboratory, medical supplies, office solutions, pharmacy, plant engineering and surgical supplies.

Some particular items of note:

  • Total Projected Pharmacy expense is expected to rise in the area of 10 percent owing to price inflation, utilization and mix of products.
  • In the area of diagnostic imaging, X-ray developing chemicals, film and related products could see increases of 50 percent or more because of the expiration of consolidated appropriations act funding, resulting in the end of reimbursement for analog produced film which used chemistry and film.
  • In the information services portfolio, telecommunications (voice and data) and wireless communication should see slight declines based on continued market competition and consolidation.
  • In foodservice, orange juice pricing will be volatile due to “greening” disease affecting Florida and other production areas.

According to Wessling, although market forces can sometimes cause unforeseen fluctuations, longstanding relationships and established contracts with suppliers provide Intalere members some stability in pricing through price protection controls and pricing being locked in for a majority of contracts.

About Intalere
Intalere’s mission focuses on elevating the operational health of America’s healthcare providers by designing tailored, smart solutions that deliver optimal cost, quality and clinical outcomes. We strive to be the essential partner for operational excellence in healthcare through customized solutions that address customers’ individual needs. We assist our customers in managing their entire spend, providing innovative technologies, products and services, and leveraging the best practices of a provider-led model. As Intalere draws on the power of our owner Intermountain Healthcare’s nationally-recognized supply chain expertise and leadership in technology, process improvement, and evidence-based clinical and business best practices, we are uniquely positioned to be the innovation leader in the healthcare industry. Visit http://www.intalere.com to learn more.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Evan Danis
Intalere
+1 (724) 778-3423
Email >
Visit website